Rocuronium Bromide Injection · 1,304 days since initial FDA posting
Brand: ROCURONIUM BROMIDE
FDA lists Rocuronium Bromide Injection as Active Shortage (Eugia US LLC).
Availability on file: Unavailable
Rocuronium Bromide Injection: Active Shortage
Unavailable Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Rocuronium Bromide Injection
- Manufacturer
- Eugia US LLC
- Dosage Form
- Injection
- Presentation
- Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 55150-226-10)
- Package NDC
- 55150-226-10
Status & Timeline
- Status
- Active Shortage
- Availability
- Unavailable
- First Reported
- Feb 15, 2023
- Last Updated
- Mar 18, 2026
- Therapeutic Category
- Anesthesia
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
On backorder. Recovery: TBD. Check wholesalers for inventory
Nearby, Other Rocuronium Shortage Records
Rocuronium Bromide Injection
Piramal Critical Care Inc.
Injection
Rocuronium Bromide Injection
Piramal Critical Care Inc.
Injection
Rocuronium Bromide Injection
Meitheal Pharmaceuticals, Inc.
Injection
Rocuronium Bromide Injection
Meitheal Pharmaceuticals, Inc.
Injection
Rocuronium Bromide Injection
Sandoz Inc.
Injection
Rocuronium Bromide Injection
Sandoz Inc.
Injection
FDA reason on file: On backorder. General shortage guidance lives on the tracker hub.